Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV

Source
Journal of medical virology - ISSN 0146-6615-96:8 (2024) p. 1-14
Author(s)

Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments

Source
The journal of clinical investigation - ISSN 0021-9738-133:6 (2023) p. 1-14
Author(s)

Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients